A detailed history of Cahill Financial Advisors Inc transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Cahill Financial Advisors Inc holds 18,249 shares of SENS stock, worth $8,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,249
Previous 18,249 -0.0%
Holding current value
$8,394
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $3,368 - $7,363
3,302 Added 22.09%
18,249 $24,000
Q1 2022

May 12, 2022

BUY
$1.54 - $3.71 $3,489 - $8,406
2,266 Added 17.87%
14,947 $29,000
Q1 2021

May 17, 2021

BUY
$0.85 - $5.27 $10,778 - $66,828
12,681 New
12,681 $33,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $214M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Cahill Financial Advisors Inc Portfolio

Follow Cahill Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Financial Advisors Inc with notifications on news.